Measurement of blood plasma HCV RNA using PCR is established as the standard of care in assessing HCV treatment and prognosis.
Highly-sensitive tests are required to ensure sustained virologic response (SVR), defined as undetectable HCV RNA following treatment.
HCV testing that provides accurate results are simple to use and test volume flexibility can enhance HCV elimination programs.
1 McHugh et al. Multicenter Evaluation of the Cepheid Xpert Hepatitis C Virus Viral Load Assay. J Clin Microbiol. 2017 May; 55(5):1550-1556. https://www.ncbi.nlm.nih.gov/pubmed/28275079 2 Shilton et al 2022, Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective threearm study. Liver Int. 2022 Apr; 42(4): 775–786 3 Thedja et al 2021, Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert® HCV Viral Load Point-of-Care Assay in Indonesia Am. J. Trop. Med. Hyg., 105(1), 2021, pp. 117–124 4 Gupta et al. Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection. J Clin Virol. 2017 Mar; 88:46-51.
The Solution
The Xpert HCV Viral Load test is designed for the rapid quantitation of Hepatitis C Virus (HCV) RNA in human serum or plasma (EDTA) from HCV-infected individuals.
The Xpert HCV Viral Load test is intended to aid in the management of HCV infected patients undergoing antiviral therapy and can be utilized to predict sustained virological responses to HCV therapy as well as confirmation of HCV infection in anti-HCV positive individuals.
The Impact
Increase Efficiency: Simplified workflow and on-demand testing reduces hands-on time1
Improve Patient Care: Fast results enable earlier adjustment to appropriate therapy2,3
1 McHugh et al. Multicenter Evaluation of the Cepheid Xpert Hepatitis C Virus Viral Load Assay. J Clin Microbiol. 2017 May; 55(5):1550-1556. https://www.ncbi.nlm.nih.gov/pubmed/28275079 2 Shilton et al 2022, Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective threearm study. Liver Int. 2022 Apr; 42(4): 775–786 3 Thedja et al 2021, Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert® HCV Viral Load Point-of-Care Assay in Indonesia Am. J. Trop. Med. Hyg., 105(1), 2021, pp. 117–124 4 Gupta et al. Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection. J Clin Virol. 2017 Mar; 88:46-51.
Related Products
Xpert HIV-1 Qual
Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in around 90 minutes
Learn more
Xpert HBV Viral Load; Tests
Detection and quantitation of Hepatitis B virus (HBV) in less than one hour
Learn more
Xpert HCV VL Fingerstick
Detection and quantitation of Hepatitis C virus (HCV) in about an hour
Learn more
Xpert HIV-1 Viral Load
Dual Target Detection for Extended Coverage and Superior Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam finibus suscipit felis, non accumsan libero fringilla vitae. Duis ut metus sed ligula condimentum porta viverra nec felis. Maecenas aliquet nisi sem, et eleifend neque egestas nec. Suspendisse euismod eget nulla at posuere. Sed cursus placerat quam a cursus. Vestibulum congue bibendum ligula ac consequat. Vestibulum pretium consequat tellus, et tempus risus sagittis posuere. Proin ac ornare enim. Maecenas aliquam, magna at sollicitudin iaculis, arcu neque rutrum enim, et semper odio mauris sed tellus.....
Ut porttitor ac diam vel egestas. Suspendisse iaculis vitae nunc eget tincidunt. Curabitur congue feugiat vestibulum. Phasellus augue massa, dapibus a tellus non, dapibus accumsan dolor.